Tell women about long term breast cancer risk with HRT, drug agency tells doctors

The UK drug regulator has asked trusts, GPs, and hospital doctors to ensure women are told about the increased risk of breast cancer associated with menopausal hormone therapy (MHT)—commonly referred to as hormone replacement therapy (HRT).1

The advice from the Medicines and Healthcare Products Regulatory Agency (MHRA) followed research recently published in the Lancet, which found that the longer women take MHT, the higher their risk …